Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061087 · ClinicalTrials.gov registry record · Phase 2
Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1
A Phase 2 study of ADHD and Opioid-Related Disorders, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 115
- Enrollment target
- 1
- Study location
NCT00061087: Completed Phase 2 study of ADHD and Opioid-Related Disorders, sponsored by New York State Psychiatric Institute.
NCT00061087 is a Phase 2 study of ADHD and Opioid-Related Disorders that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 115 participants, below the 189-participant average among 75 other ADHD trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00061087, a Phase 2 study of ADHD and Opioid-Related Disorders, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to treat Adult Attention Deficit Hyperactivity Disorder (ADHD) in methadone patients.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Methylphenidate
- DRUG Bupropion
Study Locations (1)
New York
- Research Foundation for Mental Hygiene, Inc. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 1998-02 |
| Est. Completion | 2004-10 |
| Phase | Phase 2 |
What the finished NCT00061087 record still lists
NCT00061087 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 189-participant average among 75 other ADHD trials with a reported enrollment target (39% lower).
The record links to 3 conditions, with ADHD appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00061087 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00061087 about?
NCT00061087 is a clinical study titled "Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1". The purpose of this study is to treat Adult Attention Deficit Hyperactivity Disorder (ADHD) in methadone patients.
What is the current status of trial NCT00061087?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 115 participants. The study started on 1998-02. Estimated completion is 2004-10.
What conditions does trial NCT00061087 study?
This clinical trial studies the following conditions: ADHD, Opioid-Related Disorders, Cocaine Dependence.
What interventions are being tested in trial NCT00061087?
The interventions under investigation include: Placebo (OTHER), Methylphenidate (DRUG), Bupropion (DRUG).
Who is sponsoring clinical trial NCT00061087?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00061087 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00061087's enrollment target sits among peer trials
115 30th of 75 higher than 46 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD
COMPLETED · Phase 2
-
A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
COMPLETED · Phase 2
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
RECRUITING · Phase 4
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia